Assessing and Managing Metabolic Risk in Bipolar Disorder and Schizophrenia

Assessing and Managing Metabolic Risk in Bipolar Disorder and Schizophrenia Dost Ongur, MD, PhD

Related Episodes

Continue listening to more episodes from MGH Psychiatry Academy Podcasts.

Mar 24, 2016 - 26:10

Overview: Limitations of Current Treatment of Depression Maurizio Fava, MD

Mar 24, 2016 - 43:25

Long-Acting Injectable (LAI) Antipsychotics in Bipolar Disorder and Schizophrenia Oliver Freudenreich, MD...

Mar 24, 2016 - 48:28

Assessment and Treatment of Affective Symptoms in Schizophrenia Oliver Freudenreich, MD, FAPM

Mar 24, 2016 - 19:56

Optimal Treatment of Psychosis in Bipolar Disorder Sharmin Ghaznavi, MD, PhD

Mar 24, 2016 - 45:38

Early Detection and Intervention in Bipolar Disorder and Schizophrenia Andrew A. Nierenberg, MD

Jun 16, 2014 - 35:58

Anxiety and Depression: Pharmacological Approaches Cristina Cusin, MD

Jun 16, 2014 - 46:51

Anxiety in the Setting of Depression: Risk, Comorbidity, and Residual Symptoms Naomi Simon, MD, MSc

Jun 16, 2014 - 44:00

Cognitive Dysfunction in Depressed Patients Andrew Nierenberg, MD